Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Endocardial transcription factor HAND2 orchestrates hypoxic and TGF-β signaling to modulate coronary artery formation
Huijuan Wang, Haosheng Zhang, Leiyin Zheng, Peihan Zhang, Yuqian Wang, Sijia Ding, Wenping Liu, Yuanming Cheng, Zhongzhou Yang, Wen Luo
Huijuan Wang, Haosheng Zhang, Leiyin Zheng, Peihan Zhang, Yuqian Wang, Sijia Ding, Wenping Liu, Yuanming Cheng, Zhongzhou Yang, Wen Luo
View: Text | PDF
Research Article Cardiology Vascular biology

Endocardial transcription factor HAND2 orchestrates hypoxic and TGF-β signaling to modulate coronary artery formation

  • Text
  • PDF
Abstract

The endocardium is a major source of coronary angiogenesis and arterialization, through coordinated cell fate transition and migration. However, the transcriptional regulatory network synchronizing cell fate determination and movement remains unclear. Here, we identified transcription factor HAND2 as a key candidate for coronary vascular formation. Endocardial deletion of Hand2 in mice disrupted arterial-venous networks and stunted coronary arteries, paralleling a ventricular noncompaction phenotype. Moreover, deletion of Hand2 produced excessive tip cells with defective movement. RNA-seq analysis revealed enhanced hypoxic metabolic activation but declined TGF-β/p38MAPK–dependent endothelial-mesenchymal transition. In contrast, genetic inhibition of the core hypoxic regulators or pharmaceutical administration of TGF-β2 partially recovered the coronary arterial defects in Hand2 mutants. Furthermore, HAND2 was found to directly bind to promoters of the target genes, harmonizing cell migration and cell fate transition. These findings pinpoint HAND2 as an essential regulator of the endocardial transcriptional regulatory network for coronary arterialization and provide potential therapeutic targets for coronary artery diseases.

Authors

Huijuan Wang, Haosheng Zhang, Leiyin Zheng, Peihan Zhang, Yuqian Wang, Sijia Ding, Wenping Liu, Yuanming Cheng, Zhongzhou Yang, Wen Luo

×

Figure 4

Bulk and single-cell RNA-Seq analysis in Hand2-EKO hearts revealed decreased coronary angiogenesis.

Options: View larger image (or click on image) Download as PowerPoint
Bulk and single-cell RNA-Seq analysis in Hand2-EKO hearts revealed decre...
(A) Schematic illustration of strategies for tamoxifen injection and EC preparation for bulk and single-cell RNA-seq. (B) qPCR analysis of arterial marker genes and venous marker genes. n = 4 samples per group. (C) qPCR analysis of SV-enriched and Endo-enriched genes. n = 4 samples per group. (D) Confocal images showing decreased expression of endocardial marker PLVAP and ectopic increased SV marker FABP4 in Hand2-EKO endocardium. n = 3 hearts per group. (E) UMAP representation of the ECs of control and Hand2-EKO hearts. Bar graph showing each cluster proportion in the ECs of control and Hand2-EKO hearts. (F) Dot plot showing the top 6 marker genes of subclusters. (G) The expression of Hand2 in the ECs of control and Hand2-EKO hearts. (H and I) Tip cell (H) and Endo-MT (I) module scores in Endo-Cap cell cluster. (J) Enriched GO terms of Endo-Cap differentially expressed genes. (K–M) Immunofluorescence staining demonstrates decreased Endo-MT process in Hand2 mutants. n = 3 hearts per group. (N) Western blotting analysis of Endo-MT associated markers. n = 3 samples per group. (O) Schematic showing Matrigel coronary angiogenesis assays using E12.0 left ventricular explant of Hand2-EKOBmx and control mice. (P) Representative images and quantitative analysis of EC migration. n = 8 hearts per group. (Q) Whole-mount immunostaining of E15.5 hearts for tdTomato, PECAM, and DLL4 showing migration of endocardial cells, labeled by induction at E10.5, from the endocardial layer into the myocardial layer. n = 3 hearts per group. Data represent mean ± SEM. Statistical significance was assessed using an unpaired 2-tailed Student’s t test (B, C, L, M and P). **P < 0.01, ***P < 0.001. Scale bars: 100 μm (D, K, M, P and Q). Endo-Cap, endocardial-derived capillaries; Pre-Vein, prevenous cells.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts